Davita Inc vs First Trust Cloud Computing ETF — how do they compare? Davita Inc trades at $179.75 (market cap $11.72B), while First Trust Cloud Computing ETF trades at $161.15. The key difference: First Trust Cloud Computing ETF is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals.
| DVA | SKYY | |
|---|---|---|
Market Cap | $11.72B | — |
Sector | Health | — |
52-Week High | $240.96 | $161.09 |
52-Week Low | $103.87 | $104.16 |
Enterprise Value | $24.44B | — |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
SKYY, trading at $156.17, gained 3.71% today, reflecting strong bullish momentum from moving averages and positive sentiment around cloud computing and AI trends. The ETF's technical indicators show overbought conditions with RSI levels above 76, while support is firm near $155. Recent news highlights SKYY's diversified exposure to cloud infrastructure and AI, benefiting from secular growth in digital transformation.
Outlook remains positive due to AI adoption and cloud migration tailwinds, but risks include overvaluation concerns and competitive pressures. Investors should weigh the strong technical trend against high RSI readings and monitor earnings growth for sustained upside.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →